2020, Volume 27, (online first)

April 2020

COVID-19 Bulletin 1: clinical practice in the pandemic

The COVID-19 crisis has brought with it a continual stream of information both in the lay press and also in that specifically aimed at healthcare professionals (HCPs). The purpose of our series ...

May 2020

COVID-19 bulletin 2: clinical practice in the pandemic

Welcome to the second of our COVID-19 bulletins, which we hope will help you filter the continual stream of information published in both the lay and specialist press. Our Bulletins aim to present ...

June 2020

COVID-19 bulletin 3: clinical practice in the pandemic

Welcome to the third of our COVID-19 bulletins, which we hope will help you filter the continual stream of information published in both the lay and specialist press. Our Bulletins aim to present a...

December 2020

What should nanny do next? The government and obesity

Obesity in the UK is on the up. Prevalence of obesity is higher in more deprived communities, and it is linked to a range of health conditions – as well as increasing a person’s risk from COVID-19....

December 2020

Inclisiran data shows good results LDL-C reduction across race and gender

Results from phase 3 studies with Inclisiran, a potential first-in-class small interfering RNA (siRNA) agent, have shown that it is well-tolerated and provides effective and sustained reduction in ...

December 2020

Sacubitril-valsartan benefits in cancer therapy-related cardiac dysfunction

A study from Argentina has assessed the effectiveness of sacubitril-valsartan in patients with cancer therapy-related cardiac dysfunction (CTRCD) treated in cardio-oncology units (DOI: 10.1186/s409...

December 2020

Professors Peter Sleight and Tony Gershlick

We report with great sadness, the deaths of two very distinguished cardiologists: Professors Peter Sleight (Oxford University) and Anthony (Tony) Gershlick (University of Leicester). Their contribu...

December 2020

Urgent call for more heart failure nurses

The number of specialist heart failure nurses should be increased from one to four for every 100,000 people to meet the growing demand from a rising number of heart failure cases, according to a ne...

December 2020

Dapagliflozin approved in the EU for heart failure

AstraZeneca’s sodium-glucose co-transporter-2 (SGLT2 inhibitor) dapagliflozin has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejecti...

December 2020

Women fare worse than men after severe heart attacks

Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men, according to new US research published in Circulation...